Facilitation of endoglin-targeting cancer therapy by development/utilization of a novel genetically engineered mouse model expressing humanized endoglin (CD105)
about
Anti-angiogenic alternatives to VEGF blockadeAnti-Human Endoglin (hCD105) Immunotoxin-Containing Recombinant Single Chain Ribosome-Inactivating Protein Musarmin 1.A New Theranostic System Based on Endoglin Aptamer Conjugated Fluorescent Silica Nanoparticles.Targeting Strategies for the Combination Treatment of Cancer Using Drug Delivery Systems.ALK1 signaling in development and disease: new paradigms.
P2860
Facilitation of endoglin-targeting cancer therapy by development/utilization of a novel genetically engineered mouse model expressing humanized endoglin (CD105)
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Facilitation of endoglin-targe ...... ing humanized endoglin (CD105)
@ast
Facilitation of endoglin-targe ...... ing humanized endoglin (CD105)
@en
type
label
Facilitation of endoglin-targe ...... ing humanized endoglin (CD105)
@ast
Facilitation of endoglin-targe ...... ing humanized endoglin (CD105)
@en
prefLabel
Facilitation of endoglin-targe ...... ing humanized endoglin (CD105)
@ast
Facilitation of endoglin-targe ...... ing humanized endoglin (CD105)
@en
P2093
P2860
P356
P1476
Facilitation of endoglin-targe ...... ing humanized endoglin (CD105)
@en
P2093
Ben K Seon
Hirofumi Toi
Jill Duzen
Kanako Fujita
Masanori Tsujie
Yuro Haruta
P2860
P304
P356
10.1002/IJC.28994
P577
2014-06-13T00:00:00Z